Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Jul;40(1):6-9.
doi: 10.1002/hep.20293.

Acetaminophen and the U.S. Acute Liver Failure Study Group: Lowering the Risks of Hepatic Failure

Affiliations
Review

Acetaminophen and the U.S. Acute Liver Failure Study Group: Lowering the Risks of Hepatic Failure

William M Lee. Hepatology. .

Abstract

Acetaminophen overdose is the leading cause for calls to Poison Control Centers (>100,000/year) and accounts for more than 56,000 emergency room visits, 2,600 hospitalizations, and an estimated 458 deaths due to acute liver failure each year. Data from the U.S. Acute Liver Failure Study Group registry of more than 700 patients with acute liver failure across the United States implicates acetaminophen poisoning in nearly 50% of all acute liver failure in this country. Available in many single or combination products, acetaminophen produces more than 1 billion US dollars in annual sales for Tylenol products alone. It is heavily marketed for its safety compared to nonsteroidal analgesics. By enabling self-diagnosis and treatment of minor aches and pains, its benefits are said by the Food and Drug Administration to outweigh its risks. It still must be asked: Is this amount of injury and death really acceptable for an over-the-counter pain reliever?

Comment in

Similar articles

See all similar articles

Cited by 112 articles

See all "Cited by" articles

LinkOut - more resources

Feedback